It has been reported that VLCFA-GM3 is an agonist of the TLR4 signal pathway and plays an important role in the pathogenesis of metabolic disorders through TLR4-mediated innate immune signals (29, 30). This evidence concerns the gene TLR4 and metabolic disease.